These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23755711)

  • 1. [Medication of the month. asenapine (Sycrest].
    Pitchot W
    Rev Med Liege; 2013 Apr; 68(4):196-200. PubMed ID: 23755711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
    Chwieduk CM; Scott LJ
    CNS Drugs; 2011 Mar; 25(3):251-67. PubMed ID: 21323396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asenapine: a review of acute and extension phase data in bipolar disorder.
    McIntyre RS
    CNS Neurosci Ther; 2011 Dec; 17(6):645-8. PubMed ID: 20950326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Asenapine in the Treatment of Bipolar Disorder.
    Vieta E; Montes JM
    Clin Drug Investig; 2018 Feb; 38(2):87-99. PubMed ID: 29067671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    Bipolar Disord; 2009 Nov; 11(7):673-86. PubMed ID: 19839993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Apr; 122(1-2):27-38. PubMed ID: 20096936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asenapine: Pharmacological Aspects and Role in Psychiatric Disorders.
    Reyad AA; Mishriky R
    Psychiatr Danub; 2019 Jun; 31(2):157-161. PubMed ID: 31291219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.
    Szegedi A; Zhao J; van Willigenburg A; Nations KR; Mackle M; Panagides J
    BMC Psychiatry; 2011 Jun; 11():101. PubMed ID: 21689438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials.
    Michalak EE; Guiraud-Diawara A; Sapin C
    Curr Med Res Opin; 2014 Apr; 30(4):711-8. PubMed ID: 24329543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asenapine.
    Weber J; McCormack PL
    CNS Drugs; 2009 Sep; 23(9):781-92. PubMed ID: 19689168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Nov; 126(3):358-65. PubMed ID: 20537396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder.
    Kemp DE; Zhao J; Cazorla P; Landbloom RP; Mackle M; Snow-Adami L; Szegedi A
    J Clin Psychiatry; 2014 Mar; 75(3):238-45. PubMed ID: 24499969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Asenapine Versus Olanzapine in Combination With Divalproex for Acute Mania: A Randomized Controlled Trial.
    Mahajan V; Arora M; Tandon VR; Gillani Z; Praharaj SK
    J Clin Psychopharmacol; 2019; 39(4):305-311. PubMed ID: 31205195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asenapine versus olanzapine in acute mania: a double-blind extension study.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    Bipolar Disord; 2009 Dec; 11(8):815-26. PubMed ID: 19832806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
    Landbloom RL; Mackle M; Wu X; Kelly L; Snow-Adami L; McIntyre RS; Mathews M; Hundt C
    J Affect Disord; 2016 Jan; 190():103-110. PubMed ID: 26496015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials.
    Vita A; De Peri L; Siracusano A; Sacchetti E;
    Int Clin Psychopharmacol; 2013 Sep; 28(5):219-27. PubMed ID: 23719049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asenapine: a clinical review of a second-generation antipsychotic.
    Stoner SC; Pace HA
    Clin Ther; 2012 May; 34(5):1023-40. PubMed ID: 22494521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses.
    Azorin JM; Sapin C; Weiller E
    J Affect Disord; 2013 Feb; 145(1):62-9. PubMed ID: 22868059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asenapine.
    Meltzer HY; Dritselis A; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2009 Nov; 8(11):843-4. PubMed ID: 19876039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.